|
 |
 |
Abbott gets news about trilipix: fda says yes to combo usage by 123wert sdfsf
 |
|
|
Abbott gets news about trilipix: fda says yes to combo usage |
|
|
|
Business,Business News,Business Opportunities
|
 |
Trilipix is used to treat high cholesterol and high triglyceride levels. It is sometimes given together withother cholesterol-lowering medications as it lowers blood fatscalled triglycerides while boosting quote, unquote, goodcholesterol (high-density lipoprotein). This week a FDA advisorypanel has recommended that the drug continue to me marketed in sucha fashion and in addition, Abbott be required to conduct a study inthose patients prescribed to determine if the Trilipix statin combination reduces heart attacks . This study is estimated to cost Abbott upwards of $100 millionUSD. The recommendation from that panel, which the FDA normally abidesby in their final decisions, goes against the grain considering theexistence of a government study that questioned the benefit ofusing Trilipix in combonation therapies with the popular Lipitorand Zocor for example.
A 5,000-patient government study released in Marchshowed that diabetic patients taking Trilipix plus a statin hadjust as many heart attacks as patients taking a statin aloneputting the benefit of this added element in question. Trilipix is not the first blockbuster drug that has come underscrutiny after disappointing study results. In 2008, Merck'sblockbuster cholesterol pill Vytorin was criticized after a studyshowed it was no better than a low-cost generic at reducing plaquebuildup in certain arteries. Nine out of 13 panelists voted that the drug's label should keepthe combination as an approved use.
Six voted that the label shouldbe updated with results from the government study. Three said thelabeling does not need to be changed. Abbott reported combined sales of $1.6 billion last year forTrilipix and TriCor , an older drug that contains the same active ingredient. Sales ofboth drugs are expected to decline after 2012 when TriCor losespatent protection, exposing it to low-cost generic competition.There are currently no generic Trilipix (fenofibric acid) productslicensed for sale in the United States. The earliest predictabledate that any generic versions of this medication could becomeavailable is January 2025, when the patent for Trilipix expires.
Trilipix is only part of a complete program of treatment that mayalso include diet, exercise, weight control, and other medications.Follow your diet, medication, and exercise routines very closely. There is some research on fibrates that has shown a benefit inwarding off heart attacks, although not overall mortality. Researchshows the major growth in prescriptions in the United States hascome from fenofibrate , particularly its more expensive brand-name forms. In the United States, prescriptions for fibrate medicationgenerally more than doubled from 336 prescriptions per 100,000people in 2002 to 730 prescriptions per 100,000 people in December2009.
The increase in Canada wasn't as steep, from 402 to 474 per100,000 people. And in the United States, prescriptions specifically forfenofibrate nearly tripled from 150 prescriptions for every 100,000people in 2002 to 440 for every 100,000 people in 2009. In Canada,fenofibrate's use rose much less steeply, from 321 to 429 per100,000. Sources: The Journal of the American Medical Association and The U.S. Food and Drug Administration Written by Sy Kraft. I am a professional writer from Food & Beverage, which contains a great deal of information about molecular sieve column , baseboard heaters oil, welcome to visit!
Related Articles -
molecular sieve column, baseboard heaters oil,
|
Rate This Article |
|
 |
|
Do you Agree or Disagree? Have a Comment? POST IT!
Reader Opinions |
|
 |
|
|
|
 |
 |
 |
Author Login |
|
 |
Advertiser Login
ADVERTISE HERE NOW!
Limited Time $60 Offer!
90 Days-1.5 Million Views

 |
 |
ALEX BELSEY
I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
|
 |
 |
 |
 |
STEPHEN BYE
Stephen Bye is a fiction writer. His most recent novels are a 5-book “The Developer” series which be...more
|
 |
 |
 |
 |
PAUL PHILIPS
For more articles, blog messages & videos and a free e-book download go to www.NewParadigm.ws your p...more
|
 |
 |
 |
 |
TIM FAY
After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more
|
 |
 |
 |
 |
LAURA JEEVES
At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
|
 |
 |
 |
 |
LEVAL AINAH
I am an internet marketer and also an educator. My goal is to help others who are looking to improve...more
|
 |
 |
 |
 |
GENE MYERS
Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
|
 |
 |
 |
 |
ADRIAN JOELE
I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more
|
 |
 |
 |
 |
MICHAEL BRESCIANI
Rev Bresciani is the author of two Christian books. One book is an important and concisely written b...more
|
 |
 |
|